Diabetic Peripheral Neuropathy (DPN) is one of the most common, and often overlooked, complications of diabetes. Characterized by nerve damage in the feet, legs, hands, and arms, DPN develops gradually but can have devastating consequences if left unchecked. Patients may experience numbness, burning, tingling, sharp pain, or even complete insensitivity to heat and cold. Over time, this loss of sensation can lead to foot ulcers, infections, and in severe cases, amputation. In fact, in the United States alone, a limb is amputated due to diabetes every three and a half minutes.
The tragedy is not just the damage itself, but how preventable much of it is. Early diagnosis and routine monitoring can dramatically improve patient outcomes, yet traditional diagnostic tools are often outdated, fragmented, or inaccessible at the point of care. That’s why STX4 was created.
STX4 is a breakthrough in neuropathy diagnostics, an FDA-approved, hand-held, point-of-care device designed specifically to simplify and streamline the process of diagnosing DPN. For the first time, four essential tests are integrated into one compact, battery-powered tool: the graduated monofilament test, vibration perception, and both hot and cold sensation tests. No more relying on multiple machines or subjective guesswork. STX4 delivers fast, objective, and repeatable results right at the patient’s side.
The device connects seamlessly with a HIPAA-compliant smartphone app that generates beautiful, easy-to-read patient reports. All data is securely stored in the cloud, enabling physicians to review, track, and manage each patient’s condition over time. It’s a modern solution built for modern clinical demands, portable enough for mobile clinics and assistant-friendly for use in any high-volume environment.
Beyond the technology, what makes STX4 so impactful is the clinical validation behind it. In real-world settings, providers have used the device to screen and diagnose thousands of patients, catching signs of neuropathy that might otherwise have gone unnoticed. For clinicians, it’s a practical tool. For patients, it’s a chance to intervene before it’s too late.
We believe that diagnosing diabetic neuropathy shouldn’t be cumbersome or reactive, it should be fast, simple, accurate, and part of every diabetic care routine. STX4 makes that vision a reality.
If you’re looking to improve patient outcomes while saving time and cost in your practice, we invite you to experience the difference for yourself.
Book a free demonstration and take the first step toward redefining how your clinic approaches neuropathy care.
